This work reports the effects of a previous injection of mitomycin-modified splenocytes from multiple-low dose streptozotocin-treated mice (mld-sz) on autoimmune diabetes produced by mld-sz. Our work shows that a previous inoculation of modified mononuclear splenocytes from mld-sz mice prevents alterations in glycemia, in insulin secretion (IS) pattern from isolated perifused islets, and in mass of pancreatic islets. Immunohistochemistry showed an alteration in the number of beta, but not of alpha or delta cells. While a mononuclear intra-islet infiltration was observed in mld-sz mice, a predominantly polar or peri-islet infiltration was seen in vaccinated mice. Islet-associated mononuclear cells from mld-sz mice produced diabetes and induced a diminished IS when transferred to normal receptors. Those cells from previously vaccinated mld-sz mice had no effect when injected into normal receptors. In addition, they also inhibited the damage induced in normal receptors by the islet-associated mononuclear cells from mld-sz animals. Cellular death was also prevented by previous vaccination. Our results suggest that vaccination with modified splenocytes from mld-sz mice is capable of shifting the islet cells infiltration pattern from an aggressive one toward a protective one and thus preventing the ß cell destruction observed in mld-sz mice.
CohenA, BoyerJ, WinerB. Modulating the immune response to genetic immunization. FASEB J12: 1611–1626, 1998.
3.
HaflerD, CohenI, BenjaminD, WeinerH. T cell vaccination in multiple sclerosis: a preliminary report. Clin Immunol Immunopathol62: 307–311, 1992.
4.
Van-LaarJ, MiltenburgA, VerdongM. Effect of inoculation with attenuated autologous T cells in patients with rheumatoid arthritis. J Autoimmunol6: 159–167, 1993.
5.
PaikS, FleishnerN, ShinS. Insulin dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role or cell-mediated autoimmune processes. Proc Natl Acad Sci U S A77: 6129–6133, 1980.
6.
ArataM, BrunoL, VolpiniW, QuintansC, D'alessandroV, BraunM. Basabe J. ß Cell function in mice injected with mononuclear splenocytes from multiple low-dose streptozotocin diabetic mice. Proc Soc Exp Biol Med206: 76–82, 1994.
7.
KolbH, KrönckeK. IDDM: lessons from mld-sz model mice. Diabetes Rev1: 116–126, 1993.
8.
LacyP, KostianovskyM. Method for the isolation of intact islet of Langerhans from the rat pancreas. Diabetes16: 35–39, 1967.
9.
PhillipsHJ. Dye exclusion test for cell viability. In: KruseG, PettersonC, Eds. Tissue: Methods and ApplicationsNew York: Academic Press, pp 406–408, 1973.
10.
BuschardK, RygaardJ. Passive transfer of streptozotocin induced diabetes mellitus with spleen cells. Acta Pathol Microbiol Scand85: 469–472, 1977.
11.
BurrIA., StauffacherW, BalantL, RenoldA, GrodskyG. Regulation of insulin release in perifused pancreatic tissue. Acta Diabet Lat6(Suppl 1):580–590, 1969.
WeibelE. Principle and methods for the morphometric study of the lung and other organs. Lab Invest12: 131–155, 1973.
14.
Ben-NunA, WekerleH, CohenI. Vaccination against autoimmune encephalomyelitis with T lymphocyte line cells reactive against myelin basic protein. Nature292: 60–61, 1981.
SmerdonR, PeakmanM, HussainM, VerganiD. Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse. Immunology80: 498–501, 1993.
17.
ReichE, ScaringeD, YagiJ, SherwinR, JanewayC. Prevention of diabetes in NOD mice by injection of autoreactive T-lymphocytes. Diabetes38: 1647–1651, 1989.
18.
FowellD, MasonD. Evidence that the T cell repertoire of normal rats contains cell with the potential to cause diabetes: characterization of the CD4+ T cell subset that inhibits this autoimmune potential, J Exp Med177: 627–636, 1993.
JansenA, Homo-DelarcheF, HooijkaasH, LeenenP, DardanneM, DrexhageH. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and ß cell destruction in NOD mice. Diabetes43: 667–675, 1994.
21.
YangX, MichieS, MebiusR, TischR, WeissmanI, McDevittO. The role of cell adhesion molecules in the development of IDDM. Diabetes45: 705–710, 1996.
22.
BaronJ, ReichE, VisintinI, JanewayC. The pathogenesis of adoptive murine autoimmune diabetes requires an interaction between VLA-4 integrins and vascular cell adhesion molecule-1. J Clin Invest93: 1700–1708, 1994.
23.
MartinS, HeidenthalE, SchulteB, RotheH, KolbH. Soluble forms of intercellular adhesion moleules-1 inhibit insulitis and onset of autoimmune diabetes. Diabetologia41: 1298–1303, 1998.
24.
ShimadaA, RohaneP, FathmanC, CharltonR. Pathogenic and protective roles of CD45RBlow CD4 cells correlate with cytokine profiles in spontaneously autoimmune diabetic mouse. Diabetes45: 71–78, 1996.
25.
ZekzerD, WongS, WenL, AltieriM, GurloT, von GrafensteinH, SherwingR. Inhibition of diabetes by an insulin reactive CD4 T-cell clone in the non-obese diabetic mouse. Diabetes46: 1124–1132, 1997.
26.
BrownG, SilvaM, ThompsonP, BeutlerB. Lymphoid hyperplasia, CD45RB high to CD45RB low T cell imbalance and suppression of type I diabetes mellitus result from TNF blockade in NOD-NOD-scid adoptive T cell transfer. Diabetologia41: 1502–1510, 1998.
27.
RabinovitchA. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev14: 129–151, 1998.
28.
PetersenD, van der KeurM, de VriesR, RoepB. Autoreactive and immunore gulatory T-cell subsets in insulin-dependent diabetes mellitus. Diabetologia42: 443–449, 1999.
29.
BenoistC, MathisD. Cell death mediators in autoimmune diabetes: no shortage of subjects. Cell89: 1–3, 1997.
30.
YamaokaT, YanoM, IdeharaC, YamadaT, TomonariS, MoritaniM, LiS, YoshimotoK, HataJ, ItakuraM. Apoptosis and remodeling of ß cells by paracrine interferon-γ without insulitis in transgenic mice. Diabetologia42: 566–573, 1999.
31.
ZumstegU, FrigerioS, HollanderG. Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine ß cell damage. Diabetes49: 39–47, 2000.
32.
RabinovitchA, Suarez-PinzonW, StynadkaK, JuQ, EdelsteinD, BrownleeM, KorbuttG, RajotteR. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects ß cells from cytokine-induced destruction. Diabetes48: 1223–1229, 1999.
33.
RotheH, FaustA, ShadeU, KleemannR, BosseG, HibinoT, MartinS, KolbH. Cylophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-γ, but not of interleukin-4. Diabetologia37: 1154–1158, 1994.
34.
KanetoH, FujiiJ, SeoH, SuzukiK, MatsuokaT, NakamuraM, TatsumiH, YamaakiY, KamadaT, TaniguchiN. Apoptotic cell death triggered by nitric oxide in pancreatic ß cells. Diabetes44: 733–738, 1995.
